MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
Venture Capital & Angel Investors: New Jersey
Venture Capital: New Jersey
Foundation Venture Capital Group
Parents
*Venture Capital Companies: University & Government (Institutional & Regional Focus)
Venture Capital: New Jersey
Children
Actinobac Biomed
Affineti Biologics
An affiliate of New Jersey Health Foundation it invests in commercially viable new start-up companies developing technology by faculty at UMDNJ. Since that time it has invested in five companies including:
CellXplore
Celvive
Dr. George F. Heinrich, vice chair and CEO of Foundation Venture Capital Group
Durin Technologies
Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products (2011)
Foundation Venture Capital Group Invests In Start-Up Company Working To Improve Mobility For People With Chronic Spinal Cord Injuries (2010)
Founded 2008
James M. Golubieski, president of Foundation Venture Capital Group, LLC, (FVCG)
James M. Golubieski, president of FVCG (2011)
Longevica Pharmaceuticals
Snowdon Pharmaceuticals
Jumps
UMDNJ-University Medical and Dental School of New Jersey